Incorporating ALL Biology into Treatment Decisions: Next Steps toward Targeted Therapy in Adult ALL
{{output}}
Acute lymphoblastic leukemia (ALL) management is evolving from a generalized approach toward a precision medicine paradigm driven by molecular heterogeneity. This review highlights how genomic profiling identifies high-risk subtypes, including KMT2A-rearranged... ...
